06/03/2026
multistate operator Holdings is preparing to uplist to a major U.S. stock exchange if “ongoing regulatory developments” allow it, the company said in a statement Tuesday.
In preparation, the company announced it will execute a 1-for-3 reverse stock split expected to take effect on or around June 5, the company said.
While access to markets like the New York Stock Exchange isn’t explicitly guaranteed as part of the April final order reclassifying medical cannabis as a Schedule 3 drug — and may require further action to satisfy the exchanges, which have been historically reluctant to list plant-touching cannabis businesses — Tuesday’s move fulfills at least one requirement.
Curaleaf will execute a 1-for-3 reverse stock split positioning it to uplist to a U.S. stock exchange cannabis rescheduling creates an opening to do so.